- Home
- BTAI vs BWEN Comparison
BTAI vs BWEN Comparison
Compare BTAI & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- BWEN
- Stock Information
- Founded
- BTAI 2017
- BWEN N/A
- Country
- BTAI United States
- BWEN United States
- Employees
- BTAI N/A
- BWEN N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- BWEN Industrial Machinery/Components
- Sector
- BTAI Health Care
- BWEN Industrials
- Exchange
- BTAI Nasdaq
- BWEN Nasdaq
- Market Cap
- BTAI 52.7M
- BWEN 48.4M
- IPO Year
- BTAI 2018
- BWEN N/A
- Fundamental
- Price
- BTAI $3.01
- BWEN $2.17
- Analyst Decision
- BTAI Buy
- BWEN Strong Buy
- Analyst Count
- BTAI 5
- BWEN 1
- Target Price
- BTAI $32.80
- BWEN $6.00
- AVG Volume (30 Days)
- BTAI 5.2M
- BWEN 159.9K
- Earning Date
- BTAI 11-13-2025
- BWEN 11-12-2025
- Dividend Yield
- BTAI N/A
- BWEN N/A
- EPS Growth
- BTAI N/A
- BWEN N/A
- EPS
- BTAI N/A
- BWEN N/A
- Revenue
- BTAI $868,000.00
- BWEN $145,141,000.00
- Revenue This Year
- BTAI N/A
- BWEN $8.75
- Revenue Next Year
- BTAI $614.78
- BWEN $3.50
- P/E Ratio
- BTAI N/A
- BWEN N/A
- Revenue Growth
- BTAI N/A
- BWEN N/A
- 52 Week Low
- BTAI $1.17
- BWEN $1.41
- 52 Week High
- BTAI $13.28
- BWEN $3.03
- Technical
- Relative Strength Index (RSI)
- BTAI 41.66
- BWEN 49.13
- Support Level
- BTAI $2.86
- BWEN $1.95
- Resistance Level
- BTAI $3.95
- BWEN $2.25
- Average True Range (ATR)
- BTAI 0.34
- BWEN 0.12
- MACD
- BTAI -0.17
- BWEN 0.01
- Stochastic Oscillator
- BTAI 11.89
- BWEN 52.38
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.